TAVR - A minimally invasive innovation
We are committed to providing our community with leading-edge cardiology
care, including the groundbreaking and minimally invasive TAVR (transcatheter
aortic valve replacement) procedure.
Read more about the TAVR procedure below, or call
(626) 397-2523 with any questions.
Leading the TAVR team at Huntington Hospital, Dr. Azhil (Alex) Durairaj,
MD, interventional cardiologist, and Robbin Cohen, MD, medical director
for cardiothoracic surgery (pictured), were the first in the San Gabriel
Valley to perform the less invasive TAVR procedure.
What is TAVR?
TAVR is a minimally invasive replacement of heart valves. The TAVR procedure
is a revolutionary new way to replace an aortic valve without a chest
incision or the use of a heart lung machine. Studies show patients who
have received this new device not only live longer, but feel better, and
significantly improve their quality of life.
How does TAVR work?
The TAVR procedure is performed by our dedicated Huntington Hospital heart
team using the Edwards SAPIEN 3 Transcatheter Heart Valve, an FDA approved
product. During the procedure, the team inserts a valve through a small
cut in the patient’s upper leg. The valve is advanced on a balloon
catheter through the artery toward the native and leaving the new aortic
valve in place.
Critically, TAVR eliminates the need to open the patient's chest or
use a heart-lung machine used in traditional open-heart surgeries.
Who is a candidate for TAVR?
The groundbreaking TAVR technology benefits patients with significant medical
issues in a minimally invasive fashion. The aortic valve replacement procedure
offers patients considered too ill for traditional open-heart surgery
an alternative treatment option.
Approximately 250,000 people in the United States suffer from severe aortic
stenosis. Our team of TAVR specialists provide the mest medical care to
treat these patients, many of whom are elderly with deteriorating medical
conditions and often ineligible for traditional open-heart surgery. Until
now, there has been no effective, long-term treatment option to prevent
or delay their disease progression.
Read more about our TAVR technology in our news section.